BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10561590)

  • 21. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.
    McKendrick L; Milne D; Meek D
    Mol Cell Biochem; 1999 Jan; 191(1-2):187-99. PubMed ID: 10094408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding.
    Sakaguchi K; Saito S; Higashimoto Y; Roy S; Anderson CW; Appella E
    J Biol Chem; 2000 Mar; 275(13):9278-83. PubMed ID: 10734067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the DNA binding of p53 by its interaction with protein kinase CK2.
    Prowald A; Schuster N; Montenarh M
    FEBS Lett; 1997 May; 408(1):99-104. PubMed ID: 9180277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel site of AKT-mediated phosphorylation in the human MDM2 onco-protein.
    Milne D; Kampanis P; Nicol S; Dias S; Campbell DG; Fuller-Pace F; Meek D
    FEBS Lett; 2004 Nov; 577(1-2):270-6. PubMed ID: 15527798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin.
    Siemer S; Ornskov D; Guerra B; Boldyreff B; Issinger OG
    Int J Biochem Cell Biol; 1999 Jun; 31(6):661-70. PubMed ID: 10404639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.
    Shieh SY; Ikeda M; Taya Y; Prives C
    Cell; 1997 Oct; 91(3):325-34. PubMed ID: 9363941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
    Vega FM; Sevilla A; Lazo PA
    Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export.
    Shinozaki T; Nota A; Taya Y; Okamoto K
    Oncogene; 2003 Dec; 22(55):8870-80. PubMed ID: 14654783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
    Lopez-Borges S; Lazo PA
    Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2.
    Schuster N; Prowald A; Schneider E; Scheidtmann KH; Montenarh M
    FEBS Lett; 1999 Mar; 447(2-3):160-6. PubMed ID: 10214938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
    Dumaz N; Milne DM; Jardine LJ; Meek DW
    Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
    Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
    Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A site-directed mutagenesis study of the MdmX RING domain.
    Egorova O; Mis M; Sheng Y
    Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.
    Dumaz N; Meek DW
    EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The N-terminal interferon-binding domain (IBiD) homology domain of p300 binds to peptides with homology to the p53 transactivation domain.
    Finlan L; Hupp TR
    J Biol Chem; 2004 Nov; 279(47):49395-405. PubMed ID: 15337767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expression of the human MDM2 p53 binding domain by fusion to a p53 transactivation peptide.
    Liu Z; Olejniczak ET; Fesik SW
    Protein Expr Purif; 2004 Oct; 37(2):493-8. PubMed ID: 15358376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
    Craig AL; Burch L; Vojtesek B; Mikutowska J; Thompson A; Hupp TR
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):133-41. PubMed ID: 10432310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover.
    Winter M; Milne D; Dias S; Kulikov R; Knippschild U; Blattner C; Meek D
    Biochemistry; 2004 Dec; 43(51):16356-64. PubMed ID: 15610030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.